Shareef, Mohammed, Aijaz, MD

Robert H Goslin, MD - New York Oncology Hematology is a part of The US Oncology Network, providing over 25 years of expertise in oncology practice management. The organization prioritizes patient care while offering physicians access to innovative resources, business practices, and support from McKesson, a trusted name in healthcare for more than 180 years. Committed to enhancing cancer treatment, the network facilitates participation in cutting-edge clinical trials, empowering local practices to thrive in an increasingly complex healthcare landscape. With a focus on community-based care, they ensure that independent practices have the necessary tools and resources to deliver exceptional oncology services. Generated from the website

M Siddiqu Tai, MD, is a board-certified medical oncologist affiliated with New York Oncology Hematology, providing specialized care in medical oncology and hematology at locations in Clifton Park and Amsterdam, NY. With a focus on various cancers, including breast, lung, and blood cancers, the practice offers comprehensive treatment options such as chemotherapy, immunotherapy, and clinical trials. Dr. Tai is dedicated to patient care and community service, bringing extensive training from prestigious institutions, including a hematology oncology fellowship at the Medical University of South Carolina. His commitment to advancing cancer treatment is reflected in his leadership role and active participation in professional organizations like the American Society of Clinical Oncology. Generated from the website

US Oncology, located in Amsterdam, NY, boasts over 25 years of oncology practice management expertise. The network focuses on patient care, practice health, and physician satisfaction in the ever-evolving healthcare landscape. Through The US Oncology Network, physicians have access to resources, best business practices, and the support of McKesson, a trusted healthcare name for over 180 years. With 1,400,000+ patients treated annually across 600+ sites of care, US Oncology comprises 2,700+ affiliated providers. Physicians within the network have opportunities to participate in cutting-edge clinical trials, shaping the future of cancer treatment. They play a crucial role in leading and guiding the network through various committees, ensuring they remain at the forefront of innovation. The network's commitment to excellence in cancer care is evident through its dedication to innovation in local oncology services. US Oncology offers practices access to capital for expansion, innovative clinical trials through Sarah Cannon Research Institute, and best-in-class contracting capabilities. By enabling better cancer care through a supportive network, US Oncology helps local practices maintain independence and thrive while delivering top-notch patient care. Generated from the website content